Welcome to the Towers Lab

We aim to understand the molecular details of host virus interactions, to develop novel therapeutic approaches for viral infection and to use viruses to help us understand mammalian cell biology and evolution.




Greg presented at the 2014 Conference on Retroviruses and Opportunistic Infections at Croi. His talk entitled  'HIV-1 Evades Innate Immune Recognition Through Specific Co-Factor Recruitment' is available as a podcast.


Our work on evasion of innate immunity by HIV-1 has been published in Nature

Modification of Cyclosporine A at 3' SAR position. From Rasaiyaah et al, Nature, 2013

Rasaiyaah, J., C. P. Tan, A. J. Fletcher, A. J. Price, C. Blondeau, L. Hilditch, D. A. Jacques, D. L. Selwood, L. C. James, M. Noursadeghi and G. J. Towers. 2013. HIV-1 evades innate immune recognition through specific co-factor recruitment. Nature (2013) doi:10.1038/nature12769

We are funded by Senior Biomedical Research Fellowship from the Wellcome Trust No 090940 to Professor Greg Towers and also by a European Research Council Advanced Award a Medical Research Council confidence in concept award, a UCL Business proof of concept award, the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre and the UCL MRC Centre for Medical Molecular Virology.


Wellcome Turst Logo
      NHS National Institute for Health Research Logo       MRC Centenary Logo

Page last modified on 29 mar 14 17:31 by Jane Lorna Elizabeth Turner